Callan Family Office’s Nomura Holdings NMR Stock Holding History
Bought
Maintained
Sold
Other funds holding NMR
DSC
QCM
Callan Family Office's NMR Position: Q2 2026 in Review
Callan Family Office increased its Nomura Holdings (NMR) stake by 4.2% in Q2 2026, buying an estimated $58.4K and bringing the position to 173,593 shares worth $1.52M. The position accounts for 0.03% of the portfolio, ranked #476.
Callan Family Office first reported a position in NMR in Q4 2024 and has held it in 7 quarters since. 300 funds tracked by Wall St. Rank hold NMR as of Q2 2026.
- Callan Family Office held 173,593 shares of Nomura Holdings worth $1.52M as of Q2 2026.
- Callan Family Office bought 7,017 Nomura Holdings shares in Q2 2026, an estimated $58.4K.
- Nomura Holdings made up 0.03% of Callan Family Office's portfolio in Q2 2026, its #476 holding.
- Callan Family Office first reported a position in Nomura Holdings in Q4 2024 and has held it in 7 quarters since.
- 300 funds tracked by Wall St. Rank held Nomura Holdings as of Q2 2026.
Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.